Osteosarcoma Clinical Trials in Houston, Texas

4 studies are recruiting for osteosarcoma in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

    This phase I/II trial studies the effects of trastuzumab deruxtecan (DS-8201a) in treating patients with osteosarcoma, Wilms tumor (WT) or desmoplastic small round cell tumor (DSRCT) that is newly diagnosed or has come back after a period of improvement (recurrent) or that has not responded to prev…

    Stage
    Phase 2
    Ages
    12 to 39
    Site
    Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
    Locations
    29 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04616560 on ClinicalTrials.gov

  2. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

    This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through …

    Stage
    Phase 3
    Ages
    Up to 50
    Site
    Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
    Locations
    233 in total
    Run by
    Children's Oncology Group

    See if you can join NCT05235165 on ClinicalTrials.gov

  3. Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

    This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of …

    Stage
    Not phased
    Ages
    Any age
    Site
    Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
    Locations
    79 in total
    Run by
    Children's Oncology Group

    See if you can join NCT01790152 on ClinicalTrials.gov

  4. HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

    The purpose of this study is to learn whether it is safe to give HER2-CAR T cells in combination with an immune checkpoint inhibitor drug (pembrolizumab or nivolumab), to learn what the side effects are, and to see whether this therapy might help patients with sarcoma. Another goal of this study is…

    Stage
    Phase 1
    Ages
    1 to 25
    Site
    Texas Children's Hospital, Houston, Texas
    Run by
    Baylor College of Medicine

    See if you can join NCT04995003 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.